Cell-Specific Computational Modeling of the PIM Pathway in Acute Myeloid Leukemia
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
Personalized therapy is a major goal of modern oncology, as patient responses vary greatly even within a histologically defined cancer subtype. This is especially true in acute myeloid leukemia (AML), which exhibits striking heterogeneity in molecular segmentation. When calibrated to cell-specific data, executable network models can reveal subtle differences in signaling that help explain differences in drug response. Furthermore, they can suggest drug combinations to increase efficacy and combat acquired resistance. Here, we experimentally tested dynamic proteomic changes and phenotypic responses in diverse AML cell lines treated with pan-PIM kinase inhibitor and fms-related tyrosine kinase 3 (
Description
Keywords
Journal Title
Conference Name
Journal ISSN
1538-7445
Volume Title
Publisher
Publisher DOI
Sponsorship
Medical Research Council (MC_PC_12009)
Cancer Research Uk (None)